Mitochondrial small ribosomal subunit protein uS15m: A potential drug target and biomarker

Target Name: MRPS15

NCBI ID: G64960

MRPS15

Mitochondrial small ribosomal subunit protein uS15m: A potential drug target and biomarker

Mitochondria are organelles that are responsible for generating energy in the form of ATP in cells of eukaryotic organisms. They are also involved in the production of various molecules, including proteins, lipids, and nucleotides. One of the important proteins that are synthesized in the mitochondria is the Mitochondrial Small Ribosomal Subunit Protein uS15m.

uS15m is a protein that is synthesized in the mitochondria and is involved in the production of small ribosomes, which are important for the synthesis of various proteins and other molecules. It is composed of two subunits, uS15 and uS16, and is expressed in the mitochondria of all eukaryotic organisms.

Recent studies have suggested that uS15m may have potential as a drug target and biomarker. In this article, we will explore the properties of uS15m and its potential as a drug target, as well as its potential as a biomarker for various diseases.

Properties of uS15m

uS15m is a 28kDa protein that is composed of two subunits, uS15 and uS16. It has a characteristic Rossmann-fold structure and is localized to the mitochondria. It is involved in the production of small ribosomes, which are important for the synthesis of various proteins and other molecules.

One of the important functions of uS15m is its role in the production of the protein prtidein, which is a key component of the mitochondrial matrix. Prtidein is involved in the formation of the mitochondrial intermembrane protein 2 (IMP-2), which is a protein that is involved in the regulation of mitochondrial fusion and fusion-related processes.

In addition to its role in the production of prtidein, uS15m is also involved in the regulation of mitochondrial fusion and the maintenance of mitochondrial fission. It is part of the mitochondrial fusion complex (MFC), which is responsible for regulating the fusion of mitochondrial membranes.

Potential as a drug target

The potential of uS15m as a drug target is due to its involvement in various cellular processes that are important for the development and progression of various diseases.

One of the potential mechanisms by which uS15m may be involved in the development of cancer is its role in the production of prtidein, which is a key component of the mitochondrial matrix. The production of prtidein is known to be increased in various types of cancer, and it is thought that increasing prtidein levels may contribute to the development and progression of these diseases.

In addition to its role in the production of prtidein, uS15m may also be involved in the regulation of mitochondrial fusion and the maintenance of mitochondrial fission. Its involvement in these processes suggests that it may be a potential drug target for diseases that are characterized by the disruption of these processes, such as those that are caused by mutations in the mitochondrial genome.

Potential as a biomarker

uS15m may also have potential as a biomarker for various diseases. Its involvement in the production of prtidein and the regulation of mitochondrial fusion and fission suggests that it may be a potential biomarker for diseases that are characterized by the disruption of these processes, such as those that are caused by mutations in the mitochondrial genome.

One of the potential applications of uS15m as a biomarker is its ability to be used as a diagnostic marker for diseases

Protein Name: Mitochondrial Ribosomal Protein S15

The "MRPS15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MRPS15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets